《心臟病學(xué)》以來(lái)自世界各地的高質(zhì)量論文為特色，定期向讀者介紹當(dāng)前預(yù)防、診斷和治療心臟病的策略。這些論文不僅描述了非侵入性、侵入性、診斷性和治療性方法的新發(fā)展，而且提供了批判性的評(píng)價(jià)。通過(guò)報(bào)道心臟的功能和代謝以及心血管疾病的形態(tài)學(xué)和生理學(xué)，也認(rèn)識(shí)到實(shí)驗(yàn)工作的重要性。在各種子專業(yè)領(lǐng)域的特殊部分加強(qiáng)了期刊的價(jià)值，作為所有心臟病學(xué)家、內(nèi)科醫(yī)生、心臟外科醫(yī)生和臨床生理學(xué)家的最新進(jìn)展的完整記錄?！缎呐K病學(xué)》發(fā)表有關(guān)心血管生理學(xué)、流行病學(xué)、藥理學(xué)、疾病和治療的研究和觀察的原始報(bào)告。只有英文原版論文才會(huì)被考慮。這些文章應(yīng)該易于英語(yǔ)流利的讀者理解。因此，所有來(lái)自非英語(yǔ)作者的手稿必須在提交前進(jìn)行編輯，以確保遵守標(biāo)準(zhǔn)的英語(yǔ)語(yǔ)法和用法。這可能需要同事或其他編輯助理的幫助。從求職信中可以明顯看出，這一點(diǎn)已經(jīng)做到了。沒(méi)有以這種方式編輯的投稿，在編輯完成之前不會(huì)被考慮出版。稿件應(yīng)在網(wǎng)上提交在線提交手稿 主要部分原始研究原始研究-臨床試驗(yàn)設(shè)計(jì)提交的報(bào)告將被接受，報(bào)告已在監(jiān)管部門適當(dāng)注冊(cè)的計(jì)劃臨床試驗(yàn)的研究設(shè)計(jì)方案。這些意見(jiàn)書將被限制在4500字和35參考文獻(xiàn)。審查將基礎(chǔ)研究轉(zhuǎn)化為臨床成功每期發(fā)表一至兩篇重點(diǎn)綜述文章，并應(yīng)以一種主要為臨床心臟病學(xué)家讀者所能接受的格式，對(duì)現(xiàn)有的概念和文獻(xiàn)進(jìn)行概述，即讀者基礎(chǔ)對(duì)與細(xì)胞和分子生物學(xué)相關(guān)的方法和術(shù)語(yǔ)了解有限。大多數(shù)稿件是應(yīng)邀提交的。計(jì)劃主動(dòng)投稿的作者請(qǐng)與編輯部聯(lián)系，提供投稿提綱。所有參賽作品均須經(jīng)同行評(píng)審。非訂閱者也可以免費(fèi)訪問(wèn)《華爾街日?qǐng)?bào)》網(wǎng)站上的這些文章。提交的論文不應(yīng)超過(guò)4500字和50篇參考文獻(xiàn)。他們應(yīng)該有一個(gè)大約200字的摘要和大約5個(gè)關(guān)鍵字應(yīng)該提供。致編輯的信給編輯的信(麥克斯)如果直接涉及到本期刊以前發(fā)表的文章以及這些文章所提出的問(wèn)題，則鼓勵(lì)使用1500字(包括參考文獻(xiàn))。編輯保留在發(fā)表前向有關(guān)文章的作者提交此類信件副本的權(quán)利，以便允許他們?cè)谕黄陔s志上作出答復(fù)。臨床經(jīng)驗(yàn)的新見(jiàn)解(以前的病例報(bào)告)對(duì)這部分的貢獻(xiàn)有望為臨床問(wèn)題提供新的見(jiàn)解。提交可以基于單個(gè)案例，也可以基于多個(gè)類似案例。雖然病例報(bào)告可以描述一種全新的臨床情況，但我們認(rèn)識(shí)到，大多數(shù)病例報(bào)告不太可能提供此類信息。設(shè)置更為普遍的公認(rèn)條件的描述,最重要的方面表示,將編輯判斷依據(jù),是新視角的描述(s)表型,病理生理學(xué)、臨床表現(xiàn),評(píng)價(jià)策略和/或管理可以從這樣的發(fā)現(xiàn)。在報(bào)告的第一頁(yè)，需要用高亮顯示的方框，其中包含關(guān)于“既定事實(shí)”和“新穎見(jiàn)解”的一兩個(gè)要點(diǎn)。這些應(yīng)加以選擇，以加強(qiáng)臨床觀察的新穎性。

Cardiologyí features high-quality papers from all over the world to keep its readers regularly informed of current strategies in the prevention, diagnosis and treatment of heart disease. These papers not only describe but offer critical appraisals of new developments in non-invasive, invasive, diagnostic and therapeutic methods. The importance of experimental work is also acknowledged through reports covering the function and metabolism of the heart and the morphology and physiology of cardiovascular disease. Special sections in a variety of subspecialty areas reinforce the journalís value as a complete record of recent progress for all cardiologists, internists, cardiac surgeons and clinical physiologists.''Cardiology'' publishes original reports in research and observations pertaining to cardiovascular physiology, epidemiology, pharmacology, disease and therapy.Only original papers written in English are considered. The articles should be readily comprehensible to a reader who is fluent in English. Therefore, all manuscripts originating from non-English-speaking authors must be edited prior to submission to assure that standard English grammar and usage are observed. This may require help from a colleague or other editorial assistant. It must be evident from the covering letter that this has been done. Submissions that are not edited in this way will not be considered for publication until such editing has been achieved.Manuscripts should be submitted onlineOnline Manuscript Submission Main SectionsOriginal ResearchOriginal Research – Clinical Trial DesignSubmissions will be accepted reporting the study design protocols of planned clinical trials that have been appropriately registered with regulatory authorities. These submissions will be limited to 4500 words and 35 references.ReviewTurning Basic Research into Clinical SuccessOne or two focused review articles are published in each issue, and should offer an overview of existing concepts and literature in a format assimilable to the largely clinical cardiologist readership, i.e. a readership base with limited sophistication as to methods and terminology associated with cell and molecular biology. Most manuscripts are submitted upon invitation. Authors planning to submit an unsolicited paper are requested to contact the Editorial Office with an outline of the intended contribution. All submissions are subject to peer review. These articles are available also to nonsubscribers in free access on the journal''s website. Submissions should comprise no more than 4,500 words and 50 references. They should have an abstract of approximately 200 words and about 5 key words should be provided.Letter to the EditorLetters to the Editor (max. 1,500 words, including references) are encouraged if they directly concern articles previously published in this journal and issues raised by those articles. The Editor reserves the right to submit copies of such letters to the authors of the articles concerned prior to publication in order to permit them to respond in the same issue of the journal.Novel Insights from Clinical Experience (formerly Case Reports)Contributions to this section are expected to provide novel insight into a clinical problem. Submissions can be based on a single case or a number of similar cases. While a case report can describe an entirely novel clinical condition, we recognise that it is unlikely that most case reports will provide such information. In the more common setting of a description of a well-recognized condition, the most important aspect of the presentation, on which editorial judgments will be based, is the description of the new perspective(s) on the phenotype, pathophysiology, clinical presentation, evaluation strategy and/or management that can be drawn from the case findings.Highlighted boxes containing one or two bullet points on ''Established facts''and ''Novel insights'' are required and should be placed on the first page of the report. These should be selected so as to reinforce the novelty of the clinical observation.